glp-1 receptor agonists and cardiovascular outcome trials an update Glucagon-like peptide 1 agonists: benefits mechanisms of action GLP-1 Receptor Agonists as Treatments
Description
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
(pensive music) Hey, smart people
The research-grade versus pharmaceutical-grade distinction becomes critical here
Potential winners include drug makers, suppliers and consumer-focused businesses that manufacture healthy foods
Hormonal therapies included Arimidex (anastrozole), tamoxifen, Aromasin (exemestane), and Femara (letrozole)
